Why This Analyst Sees AT&T Undervalued by 20%
Jefferies reiterated its price target on AT&T, noting the ways in which the company is well-positioned to meet future demands.
All Work
Chris Lange
Why Credit Suisse Sees iPhone 7 Orders Going Through the Roof
The attention around the upcoming release of the iPhone 7 is making analysts think that this could be a better than expected iPhone cycle in both volume in mix.
Why This Goodyear Dividend Hike Could Get Even Larger
Goodyear Tire & Rubber has announced its updated financial performance targets and a solid dividend hike, as increasing demand for larger, more profitable tires has boosted the business.
Philly Fed Survey Sees Manufacturing on the Rise
The Philly Fed Survey signaled that manufacturing conditions continued to improve, with positive indicators for general activity and new orders increasing from their August numbers.
Why Aeri Pharma Won So Big on a Single Trial
Shares of Aeri Pharmaceuticals skyrocketed early Thursday after the company issued positive results on its intraocular pressure (IOP) treatment in patients with glaucoma.
Why This FDA Departure Is Huge for Sarepta
Sarepta Therapeutics closed out Wednesday with its shares up over 25% following positive developments surrounding eteplirsen, its treatment of Duchenne muscular dystrophy.
What to Expect From Oracle Earnings
Oracle Corp. (NYSE: ORCL) is scheduled to report its fiscal first-quarter financial results after markets close on Thursday. The consensus estimates from Thomson Reuters are calling for $0.58 in earnings per share (EPS) and…
Jeld-Wen Prepares for IPO
Jeld-Wen Holding has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Will Carl Icahn Take Herbalife Private?
Carl Icahn believes that Herbalife might be better off as a privately held firm and he has weighed the possibility of launching a tender offer for it.
Cracker Barrel Earnings Report Slips on Guidance
Cracker Barrel Old Country Store released disappointing fiscal fourth-quarter financial results before the markets opened on Wednesday.
At Home Scores on Q2 Earnings
At Home Group reported its fiscal second-quarter financial results after the markets closed on Tuesday, and shares rallied early Wednesay.
Agios Files for Secondary Offering
Agios Pharmaceuticals has filed with the SEC regarding a secondary offering of up to $150 million of its common stock.
Vitae Shares Jump Over 150% on Allergan Acquisition
The goal of Allergan’s bid for Vitae Pharmaceuticals is to bolster its dermatology product pipeline, and Vitae shareholders appear happy to oblige.
Glu Mobile Moves to Acquire Poke Radar
Glu Mobile announced early on Wednesday that it is moving to acquire the community-driven app Poke Radar.
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in late-September and October.
2 Major Semiconductor Upgrades That Cannot Be Ignored
Is the air is coming out of the tech rally ahead of a potential rate hike? Possibly, but a couple of analysts have picked out a few stocks that can weather this storm.
Pandora Shares Sink With New Direct Licensing Agreements
Pandora Media shares slid after the company announced that it signed direct licensing agreements for recorded music from over 30 other independent labels and distributors.
Renesas Moves to Acquire Intersil
Shares of Intersil saw a handy gain on Tuesday after Japanese chip maker Renesas Electronics announced that it will acquire the company for more than $3 billion.
Jefferies Issues Top Pharma and Biohealth Stocks to Buy
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
Blue Buffalo Announces Secondary Offering
Blue Buffalo Pet Products has filed with the SEC regarding a secondary offering of some 14.3 million shares.